Clinical Topics & News

Innovations in Dermatology: Brodalumab for Plaque Psoriasis

Publish date: October 10, 2017

In February 2017, the US Food and Drug Administration approved injectable brodalumab (210 mg) to treat patients with moderate to severe plaque...

We applaud Kimball et al¹ on their report that adalimumab demonstrated clinical improvement in patients with hidradenitis suppurativa (...

Author:: Peter W. Hashim, MD, MHS; Joel L. Cohen, MD; David T. Pompei, PharmD, MS; Gary Goldenberg, MD

Topical cannabinoids are increasingly utilized by dermatology patients for a range of disorders; however, the acceptance of these over-the-counter...

Publish date: June 12, 2017

The aim of this study was to investigate the effects of narrowband UVB (NB-UVB) phototherapy on serum 25-hydroxyvitamin D (25[OH]D) levels and...

Currently, there is no widely accepted tool for assessing the severity of psoriasis in the clinical setting.1-5 Moreover, there is still a need...

Publish date: May 1, 2017

Both alopecia areata (AA) and psoriasis vulgaris are chronic relapsing autoimmune diseases, with AA causing nonscarring hair loss in approximately...

Publish date: April 6, 2017